Additionally, there are no significant differences in the levels of keratin 17 between tumors and normal tissues in urothelial bladder carcinoma (BLCA), papillary carcinoma of the kidney (KIRP), or pancreatic adenocarcinoma (PAAD) [16]. The gene discussed is KRT17; the disease is bladder transitional cell carcinoma.